HOME >> BIOLOGY >> NEWS
At Berkeley: Intelligently designed molecular evolution

Evolutionary paths to new therapeutic drugs, as well as a wide assortment of other enzyme products, have been created through, of all things, intelligent design. A team of researchers with the Lawrence Berkeley National Laboratory (Berkeley Lab) and the University of California at Berkeley have developed a technique in which the evolution of an important class of proteins is steered towards a desired outcome.

"We've taken enzymes that are promiscuous, meaning they have the capacity to evolve along many different functional lines, and trained them to become specialists," said chemical engineer Jay Keasling, who led this study.

"This technology could be used by pharmaceutical manufacturers in the future to create specific enzyme products."

Keasling is director of Berkeley Lab's Physical Biosciences Division, and a professor of chemical engineering with UC Berkeley's Chemical Engineering Department. Collaborating with him on this project were his graduate student, Yasuo Yoshikuni, and Thomas Ferrin, a professor of pharmaceutical chemistry and biopharmaceutical sciences at UC San Francisco.

The results of this study were reported in the February 22, 2006, on-line edition of the journal Nature.

According to the theory of divergent molecular evolution, primordial enzymes and other proteins started out as "promiscuous" so that primitive organisms would be better able to adapt to their environment. Driven by selective pressures, these promiscuous enzymes and other proteins evolved along divergent lines to acquire the specialized functions needed by a host organism to survive.

"This process is highly dependent on the fact that the functions of promiscuous proteins can be altered with just a small number of amino acid substitutions, a property known as plasticity," said Keasling. "It was our contention that the application of the theory of divergent molecular evolution to promiscuous enzymes would enable us to design enzym
'"/>

Contact: Lynn Yarris
lcyarris@lbl.gov
510-486-5375
DOE/Lawrence Berkeley National Laboratory
23-Feb-2006


Page: 1 2 3

Related biology news :

1. Alzheimers drug based on Purdue -- designed inhibitor begins clinical trials
2. Computer-designed molecule to clean up fluorocarbons?
3. Georgia Tech computer program designed to halt pandemics installed in Georgia
4. Redesigned protein accelerates blood clotting
5. INEEL-designed system assists army with chemical weapon destruction
6. New textbook illuminates the close links between evolutionary and molecular biology
7. New molecular regulators of hyperthyroidism and goiter
8. A novel molecular dictator with a conscience discovered
9. UC Santa Barbara scientists clarify molecular basis of interferon action
10. MU researchers make discovery in molecular mechanics of phototropism
11. Malaria-resistant mosquitoes battle disease with molecular warhead

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/29/2020)... (PRWEB) , ... January 29, 2020 , ... ... receptor and in vitro toxicology testing solutions, has announced a record earnings year ... upcoming weeks, INDIGO showed more than a twenty percent increase in revenue and ...
(Date:1/28/2020)... Mass. (PRWEB) , ... January 28, 2020 , ... ... for life sciences companies and government agencies, announced that the firm has established ... the country. Tunnell’s Cambridge office will be in the Cambridge Innovation Center (CIC), ...
(Date:1/27/2020)... ... 27, 2020 , ... On Thursday, February 20, 2020 at 10am EST (3pm ... and Richard Castle, Global Account Manager Medical Device at PRISYM ID ... EU MDR timing deadlines, best practices in creating and submitting product data and best ...
Breaking Biology News(10 mins):
(Date:2/19/2020)... ... February 19, 2020 , ... Red Nucleus, a ... industry, today announced the opening of a new office in Tokyo, Japan. The ... , Red Nucleus announced the new office in response to customer requests for ...
(Date:2/10/2020)... ... ... R3 Medical Training announced it is now registering for its next Comprehensive ... hands on involving real patients and stem cell biologics, with every attendee receiving a ... Course has received rave reviews from attendees, who love the hands on nature of ...
(Date:2/3/2020)... Hungary and CAMBRIDGE, Mass. (PRWEB) , ... February ... ... in Budapest with US offices in Cambridge, MA, announce that OmniType, the 11-locus, ... Program (EAP) from today. OmniType is a best-in-class product featuring locus-multiplexing and short ...
(Date:1/27/2020)... ... January 27, 2020 , ... ... neuroscience and cloud and mobile computing, today announced the availability of neuroscience of ... organization to use the latest neuroscience of leadership and change research to become ...
Breaking Biology Technology:
Cached News: